Scientists discover new method for engineering human tissue regeneration

May 12, 2011, Federation of American Societies for Experimental Biology

If pending clinical trials prove successful, a new discovery published in The FASEB Journal could represent a major scientific leap toward human tissue regeneration and engineering. In a research report appearing online, Yale scientists provide evidence to support a major paradigm shift in this specialty area from the idea that cells added to a graft before implantation are the building blocks of tissue, to a new belief that engineered tissue constructs can actually induce or augment the body's own reparative mechanisms, including complex tissue regeneration.

"With the constant growing clinical demand for alternative vessels used for vascular reconstructive surgeries, a significant development for alternative grafts is currently the primary focus of many investigators worldwide," said Christopher K. Breuer, M.D., a researcher involved in the work from Yale University School of Medicine/Yale-New Haven Hospital in New Haven, CT. "We believe that through an understanding of human vascular biology, coupled with technologies such as tissue engineering, we can introduce biological grafts that mimic the functional properties of native vessels and that are capable of growing with the patients." Breuer also says that patients are currently being enrolled in a first-of-its-kind clinical trial at Yale University to evaluate the safety and growth potential of tissue-engineered vascular grafts in children undergoing surgery for .

To make this discovery, Breuer and colleagues conducted a three-part study, starting with two groups of mice. The first group expressed a gene that made all of its fluorescent green and the second group was normal. Researchers extracted cells from the "green" mice, added them to previously designed scaffolds, and implanted the grafts into the normal mice. The seeded bone marrow cells improved the performance of the graft; however, a rapid loss of green cells was noted and the cells that developed in the new were not green, suggesting that the seeded cells promoted vessel development, but did not turn into vessel wall cells themselves. These findings led to the second part of the study, which tested whether cells produced in the host's bone marrow might be a source for new cells. Scientists replaced the bone marrow cells of a female mouse with those of a male mouse before implanting the graft into female mice. The researchers found that the cells forming the new vessel were female, meaning they did not come from the male . In the final experiment, researchers implanted a segment of male vessel attached to the scaffold into a female host. After analysis, the researchers found that the side of the graft next to the male segment developed with male vessel wall cells while the side of the graft attached to the female host's vessel formed from female cells, proving that the cells in the new vessel must have migrated from the adjacent normal vessel.

"There's a very good chance that this study will eventually have a major impact on many disorders that afflict humankind," said Gerald Weissmann, M.D., Editor-in-Chief of The . "These scientists have basically used the body's repair mechanisms to make new tissues through bioengineering. In years to come, starfish and salamanders will have nothing on us!"

More information: Narutoshi Hibino, Gustavo Villalona, Nicholas Pietris, Daniel R. Duncan, Adam Schoffner, Jason D. Roh, Tai Yi, Lawrence W. Dobrucki, Dane Mejias, Rajendra Sawh-Martinez, Jamie K. Harrington, Albert Sinusas, Diane S. Krause, Themis Kyriakides, W. Mark Saltzman, Jordan S. Pober, Toshiharu Shin'oka, and Christopher K. Breuer. Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel. FASEB J. doi:10.1096/fj.11-182246

Related Stories

Recommended for you

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...

The HLF gene protects blood stem cells by maintaining them in a resting state

January 17, 2018
The HLF gene is necessary for maintaining blood stem cells in a resting state, which is crucial for ensuring normal blood production. This has been shown by a new research study from Lund University in Sweden published in ...

Magnetically applied MicroRNAs could one day help relieve constipation

January 17, 2018
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.

Researchers devise decoy molecule to block pain where it starts

January 16, 2018
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he's developing new ways to blunt pain.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.